Suven Pharmaceuticals board to consider financial results & final dividend

01 Jun 2021 Evaluate

Suven Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on June 08, 2021, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and for the year ending March 31, 2021; and to consider and recommend a final dividend, if any, for the financial year ending March 31, 2021. Further note that trading window for dealing in the securities of the Company is already closed from April 01, 2021 as per PIT Code of the Company. Trading window will be opened from June 11, 2021.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

542.20 -6.90 (-1.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×